We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Open Endoscopic Vessel Harvesting System Offers Improved Ergonomics

By HospiMedica International staff writers
Posted on 17 May 2011
A novel open carbon dioxide (CO2) endoscopic vessel harvesting (EVH) system can significantly lessen the complication of clot formation, when compared with a sealed EVH system. More...


The VascuClear EVH system is a truly open CO2 system, and thus is not reliant on sealed gas insufflation and carries little to no risk of CO2 embolism or intraluminal clot formation. A precision bipolar design offers several improvements, including an easy-to-use textured button configuration to provide a better feel and grip, and spring-loaded controls to return the jaw to a neutral position when released. A bright tip on the jaw improves visibility, and handles inside the harvesting tunnel provide an improved ergonomic feel, keeping cords out of the way. The system also operates at a low temperature, minimizing thermal spread.

Other features include greater flexibility, and a smooth cut and seal that require no additional "tugging” on the vessel. The proprietary Bonchek Vein Distention system distends and irrigates a vein graft to a predetermined level to avoid over-distention of the harvested vessel. The VascuClear system is delivered in visibly clear, recyclable packaging and is conveniently organized and easy to open for immediate use. The VascuClear EVH system is a product of the Sorin Group (Milan, Italy).

"The introduction of VascuClear provides clinicians with the newest tool for minimally invasive endoscopic vessel harvesting and strengthens our comprehensive line of cardiovascular products and services,” said Michel Darnaud, president of the cardiopulmonary and intercontinental business units at the Sorin Group.

EVH uses specialized instruments to view and remove a healthy blood vessel for harvesting during coronary artery bypass graft (CABG) surgery, with minimal trauma to the vessel or surrounding tissues. In clinical studies, EVH has shown important benefits, including a reduced risk of infection and wound complications; less postoperative pain and swelling; and faster recovery with minimal scarring. The reduction in pain allows patients to get back on their feet and return to normal mobility much sooner, along with a reduced length of hospital stay.

Related Links:

Sorin Group



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.